Cargando…

Radiolabelled monoclonal antibodies in the treatment of metastatic cancer

Detalles Bibliográficos
Autor principal:	Goldenberg, D.M.
Formato:	Texto
Lenguaje:	English
Publicado:	Multimed Inc. 2007
Materias:	Updates and Developments in Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891189/ https://www.ncbi.nlm.nih.gov/pubmed/17576463

Ejemplares similares

Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer
por: Kraeber–Bodéré, F., et al.
Publicado: (2009)

Promising agents for chemoprevention of skin cancer
por: Stratton, S.P., et al.
Publicado: (2006)

Localisation of metastatic carcinoma by a radiolabelled monoclonal antibody.
por: Smedley, H. M., et al.
Publicado: (1983)

The role of dna hypermethylation and demethylation in cancer and cancer therapy
por: Szyf, M.
Publicado: (2008)

Are matrix metalloproteinases relevant therapeutic targets for prostate cancer bone metastasis?
por: Bonfil, R.D., et al.
Publicado: (2008)

Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics
por: Williams, P.D., et al.
Publicado: (2009)

Receptor tyrosine kinases: role in cancer progression
por: Sangwan, V., et al.
Publicado: (2006)

Role of vaccine therapy in cancer: biology and practice
por: Schlom, J., et al.
Publicado: (2007)

Cancer and thrombosis: recent advances
por: Solymoss, S.
Publicado: (2008)

Anal cancer and human papillomaviruses in heterosexual men
por: Nyitray, A.
Publicado: (2008)

Targeting transforming growth factor β to enhance cancer immunotherapy
por: Hahn, T., et al.
Publicado: (2006)

Cancer symptom control trials: how may we advance this field?
por: MacDonald, N.
Publicado: (2007)

Hepatocyte growth factor and the hepatocyte growth factor receptor signalling complex as targets in cancer therapies
por: Jiang, W.G.
Publicado: (2007)

Exosomes in tumour immunity
por: Clayton, A., et al.
Publicado: (2009)

Radiofrequency ablation and cryoablation of renal tumours
por: Kwan, K.G., et al.
Publicado: (2007)

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?
por: Gainford, M.C., et al.
Publicado: (2006)

Electrochemotherapy of tumours
por: Sersa, G., et al.
Publicado: (2009)

Retinoids, vitamin D, invasion, and metastasis
por: Tokar, E.J., et al.
Publicado: (2006)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008)

Radiation oncology: Times of practice change
por: Freeman, C.R., et al.
Publicado: (2007)

Recent advances in the tumour biology of the GPI-anchored carcinoembryonic antigen family members CEACAM5 and CEACAM6
por: Chan, C.H.F., et al.
Publicado: (2007)

Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-Resistant Prostate Cancer
por: Tagawa, Scott T., et al.
Publicado: (2013)

Radiolabeled Monoclonal Antibody Against Colony-Stimulating Factor 1 Receptor Specifically Distributes to the Spleen and Liver in Immunocompetent Mice
por: Waaijer, Stijn J. H., et al.
Publicado: (2021)

Monoclonal Antibodies Radiolabeling with Rhenium-188 for Radioimmunotherapy
por: Uccelli, Licia, et al.
Publicado: (2017)

Efficacy of the monoclonal antibody EGFR inhibitors for the treatment of metastatic colorectal cancer
por: Fakih, M., et al.
Publicado: (2010)

Heptadentate chelates for (89)Zr-radiolabelling of monoclonal antibodies
por: Guillou, Amaury, et al.
Publicado: (2022)

Microbes and colorectal cancer: is there a relationship?
por: Uronis, J.M., et al.
Publicado: (2009)

Detection of Locally Recurrent Colorectal Cancer with Radiolabeled Monoclonal Antibody H‐15
por: Sakamoto, Junichi, et al.
Publicado: (1992)

Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990)

Update to a randomized controlled trial of lutetium-177-PSMA in Oligo-metastatic hormone-sensitive prostate cancer: the BULLSEYE trial
por: Privé, Bastiaan M., et al.
Publicado: (2021)

Current Status of Radiolabeled Monoclonal Antibodies Targeting PSMA for Imaging and Therapy
por: Abusalem, Mohammed, et al.
Publicado: (2023)

Localization of human tumour xenografts after i.v. administration of radiolabeled monoclonal antibodies.
por: Moshakis, V., et al.
Publicado: (1981)

A radiolabeled monoclonal antibody binding assay for cytoskeletal tubulin in cultured cells
Publicado: (1986)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Localisation of lung cancer by a radiolabelled monoclonal antibody against the c-myc oncogene product.
por: Chan, S. Y., et al.
Publicado: (1986)

Fixed Dosing of Monoclonal Antibodies in Oncology
por: Hendrikx, Jeroen J.M.A., et al.
Publicado: (2017)

Evaluating the treatment of metastatic colorectal cancer with monoclonal antibodies
por: Popa, C, et al.
Publicado: (2012)

Radiolabeled Antibodies for Cancer Imaging and Therapy
por: Parakh, Sagun, et al.
Publicado: (2022)

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
por: Bruland, O., et al.
Publicado: (1987)

Cannot write session to /tmp/vufind_sessions/sess_ee1pjvgh4d0luf02vaq1osd4vq